ASND
Price
$199.59
Change
+$2.35 (+1.19%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
11.79B
57 days until earnings call
NUVL
Price
$78.71
Change
+$0.38 (+0.49%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
5.72B
50 days until earnings call
Interact to see
Advertisement

ASND vs NUVL

Header iconASND vs NUVL Comparison
Open Charts ASND vs NUVLBanner chart's image
Ascendis Pharma A/S
Price$199.59
Change+$2.35 (+1.19%)
Volume$5.56K
Capitalization11.79B
Nuvalent
Price$78.71
Change+$0.38 (+0.49%)
Volume$7.45K
Capitalization5.72B
ASND vs NUVL Comparison Chart in %
Loading...
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASND vs. NUVL commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a Hold and NUVL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (ASND: $197.24 vs. NUVL: $78.33)
Brand notoriety: ASND and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 46% vs. NUVL: 53%
Market capitalization -- ASND: $11.79B vs. NUVL: $5.72B
ASND [@Biotechnology] is valued at $11.79B. NUVL’s [@Biotechnology] market capitalization is $5.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • ASND’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than ASND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 3 TA indicator(s) are bullish while NUVL’s TA Score has 6 bullish TA indicator(s).

  • ASND’s TA Score: 3 bullish, 5 bearish.
  • NUVL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than ASND.

Price Growth

ASND (@Biotechnology) experienced а -2.79% price change this week, while NUVL (@Biotechnology) price change was -0.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.35%. For the same industry, the average monthly price growth was +5.87%, and the average quarterly price growth was +34.62%.

Reported Earning Dates

ASND is expected to report earnings on Nov 13, 2025.

NUVL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASND($11.8B) has a higher market cap than NUVL($5.72B). ASND YTD gains are higher at: 43.267 vs. NUVL (0.064). ASND has higher annual earnings (EBITDA): -161.68M vs. NUVL (-362.01M). NUVL has more cash in the bank: 1.01B vs. ASND (518M). ASND has higher revenues than NUVL: ASND (491M) vs NUVL (0).
ASNDNUVLASND / NUVL
Capitalization11.8B5.72B206%
EBITDA-161.68M-362.01M45%
Gain YTD43.2670.06467,734%
P/E RatioN/AN/A-
Revenue491M0-
Total Cash518M1.01B51%
Total Debt847MN/A-
FUNDAMENTALS RATINGS
ASND: Fundamental Ratings
ASND
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASNDNUVL
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 15 days ago
73%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EBUF28.03N/A
N/A
Innovator Emerging Markets 10 Buf ETF-Qt
AVIV67.24-0.02
-0.03%
Avantis International Large Cap Val ETF
PSFJ32.29-0.01
-0.03%
Pacer Swan SOS Flex (July) ETF
BCHG4.18-0.01
-0.36%
Grayscale Bitcoin Cash Trust (BCH)
REKT16.92-0.24
-1.37%
Direxion Daily Crypto Industry Bear1XETF

ASND and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with ZNTL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then ZNTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
+1.34%
ZNTL - ASND
40%
Loosely correlated
-2.07%
NUVL - ASND
40%
Loosely correlated
-1.31%
ORMP - ASND
37%
Loosely correlated
-1.29%
AMRN - ASND
35%
Loosely correlated
N/A
AXON - ASND
34%
Loosely correlated
-1.33%
More

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with CGON. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
-1.31%
CGON - NUVL
54%
Loosely correlated
+3.35%
ABCZF - NUVL
51%
Loosely correlated
N/A
RVMD - NUVL
51%
Loosely correlated
-3.25%
NRIX - NUVL
51%
Loosely correlated
-2.65%
KYMR - NUVL
50%
Loosely correlated
+3.17%
More